Accenture logged net income of about $2.2 billion, or $3.49 a share, for the third quarter ended May 31, compared to $1.93 billion, or $3.04 a share, in the prior-year period. Analysts polled by ...

Here's the brutal truth: You can't live your niece's life for her.

This isn't the first time energy stocks have zigged while everything else has zagged. It seems to be a feature, not a bug. U.S. and global stock markets have fallen since Israel attacked Iran just ...

Your niece's husband has a choice about whether to feel alienated or not. Given that he owns his own home and, assuming he is aware that his wife would like to have a home of her own and to maintain ...

The gain in Circle Financial's stock since its IPO on June 5 has outperformed other fintech IPOs by a wide margin. Crypto brokerage eToro Group Ltd.'s stock (ETOR) closed Wednesday 21.9% above its IPO ...

"Very few people understand what they need to know to help them prepare financially for the future," said Sexton, a certified financial planner in Hudson, Ohio. "There's a lot of ignorance out there ...

Kroger is not the only company to identify this trend. Earlier this month food giant Campbell's Co. (CPB) noted a boost in its meals-at-home business. In contrast, restaurant chains such as McDonald's ...

Telomeres are the crucial protective caps at the ends of our DNA strands (they are sometimes compared to the plastic caps at the ends of shoelaces), and they are critical to cellular health. They ...

Used-car retailer CarMax logged higher profit and sales in its latest quarter as tariff uncertainty sparked an uptick in demand for used cars. It is the first time Rheinmetall will join the ...

Federal Reserve governor Christopher Waller said the central bank could be positioned to cut interest rates at its next meeting in July, notwithstanding potential inflation pressures caused by new ...

Despite that setback, there's optimism, and caregiving advocate and labor activist Ai-jen Poo, who is author of "The Age of Dignity: Preparing for the Elder Boom in a Changing America," provided this ...

The results for Lunsumio, also known as mosunetuzumab, and Polivy, also known as polatuzumab vedotin, came as part of a phase 3 study. Roche said it would now submit results to global health ...